Total Payments
$2,285
2024 Payments
$115.54
Companies
10
Transactions
30
Medicare Patients
12,508
Medicare Billing
$5.9M
Payment Breakdown by Category
Food & Beverage$2,276 (99.6%)
Education$9.20 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,276 | 29 | 99.6% |
| Education | $9.20 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $377.87 | 4 | $0 (2022) |
| PFIZER INC. | $375.14 | 3 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $365.65 | 13 | $0 (2023) |
| ABBVIE INC. | $359.53 | 3 | $0 (2022) |
| UCB, Inc. | $249.99 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $124.52 | 1 | $0 (2021) |
| Mallinckrodt Hospital Products Inc. | $122.91 | 1 | $0 (2023) |
| ANI Pharmaceuticals, Inc. | $115.54 | 1 | $0 (2024) |
| Gilead Sciences Inc | $106.60 | 1 | $0 (2017) |
| Lilly USA, LLC | $87.62 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.54 | 1 | ANI Pharmaceuticals, Inc. ($115.54) |
| 2023 | $222.20 | 6 | Mallinckrodt Hospital Products Inc. ($122.91) |
| 2022 | $463.35 | 10 | Amgen Inc. ($130.98) |
| 2021 | $146.92 | 2 | AstraZeneca Pharmaceuticals LP ($124.52) |
| 2020 | $124.99 | 1 | AbbVie Inc. ($124.99) |
| 2019 | $496.24 | 4 | PFIZER INC. ($247.49) |
| 2018 | $499.53 | 4 | Amgen Inc. ($246.89) |
| 2017 | $216.60 | 2 | AbbVie, Inc. ($110.00) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/22/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $115.54 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 03/23/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Dermatology | ||||||
| 03/21/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $122.91 | General |
| Category: IMMUNOLOGY | ||||||
| 03/10/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Dermatology | ||||||
| 03/07/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Dermatology | ||||||
| 02/02/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Dermatology | ||||||
| 01/05/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Dermatology | ||||||
| 11/02/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | Cash or cash equivalent | $87.62 | General |
| Category: Immunology | ||||||
| 08/30/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: IMMUNOLOGY | ||||||
| 07/28/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: IMMUNOLOGY | ||||||
| 06/29/2022 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $121.78 | General |
| Category: Bone Health | ||||||
| 06/23/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: IMMUNOLOGY | ||||||
| 06/02/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.54 | General |
| Category: IMMUNOLOGY | ||||||
| 04/28/2022 | Amgen Inc. | — | Education | In-kind items and services | $9.20 | General |
| 04/14/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2021 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $124.52 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 08/30/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: IMMUNOLOGY | ||||||
| 01/30/2020 | AbbVie Inc. | RINVOQ (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $123.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/20/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 06/27/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $123.75 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $123.74 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/07/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 884 | 29,700 | $712,813 | $184,127 |
| 2022 | 42 | 3,482 | 199,409 | $7.4M | $2.0M |
| 2021 | 53 | 4,009 | 201,958 | $7.0M | $2.0M |
| 2020 | 42 | 4,133 | 164,000 | $6.0M | $1.8M |
Total Patients
12,508
Total Services
595,067
Medicare Billing
$5.9M
Procedure Codes
158
All Medicare Procedures & Services
158 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 20 | 15,200 | $304,000 | $58,876 | 19.4% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 14 | 11,040 | $121,440 | $51,717 | 42.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 41 | 2,460 | $105,780 | $43,041 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 141 | $46,812 | $11,636 | 24.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 46 | 71 | $67,017 | $7,511 | 11.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 31 | $7,037 | $1,846 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $5,352 | $1,712 | 32.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 131 | 157 | $1,413 | $1,319 | 93.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 40 | 40 | $8,000 | $1,160 | 14.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 83 | 87 | $5,046 | $900.45 | 17.8% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 14 | 31 | $4,371 | $822.27 | 18.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 65 | 85 | $7,480 | $747.26 | 10.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 17 | 18 | $5,634 | $692.42 | 12.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 69 | 72 | $2,088 | $547.92 | 26.2% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 15 | 75 | $15,450 | $448.90 | 2.9% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 60 | 73 | $1,241 | $305.14 | 24.6% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 44 | 55 | $1,375 | $279.40 | 20.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 14 | 15 | $1,125 | $246.90 | 21.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 11 | 11 | $902.00 | $144.32 | 16.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 11 | 11 | $440.00 | $91.19 | 20.7% |
| 86431 | Rheumatoid factor level | Office | 2023 | 15 | 15 | $810.00 | $83.40 | 10.3% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2022 | 24 | 88,044 | $968,484 | $409,494 | 42.3% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 26 | 10,754 | $1.4M | $373,507 | 26.7% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 30 | 75,600 | $1.5M | $339,838 | 22.5% |
| J9312 | Injection, rituximab, 10 mg | Office | 2022 | 24 | 4,401 | $1.1M | $294,042 | 26.4% |
About Dr. Jack Berger, MD
Dr. Jack Berger, MD is a Rheumatology healthcare provider based in Purchase, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1770568719.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Berger, MD has received a total of $2,285 in payments from pharmaceutical and medical device companies, with $115.54 received in 2024. These payments were reported across 30 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,276).
As a Medicare-enrolled provider, Berger has provided services to 12,508 Medicare beneficiaries, totaling 595,067 services with total Medicare billing of $5.9M. Data is available for 4 years (2020–2023), covering 158 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location Purchase, NY
- Active Since 12/13/2005
- Last Updated 01/21/2016
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1770568719
Products in Payments
- XELJANZ (Drug) $375.14
- COSENTYX (Biological) $266.36
- Cimzia (Drug) $249.99
- Enbrel (Biological) $125.00
- RINVOQ (Drug) $124.99
- RINVOQ (Biological) $124.54
- SAPHNELO (Biological) $124.52
- ACTHAR (Biological) $122.91
- EVENITY (Biological) $121.78
- PURIFIED CORTROPHIN GEL (Drug) $115.54
- Humira (Biological) $110.00
- COSENTYX (Drug) $99.29
- TALTZ (Drug) $87.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.